VAERS 1672477
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge END187
- Staat
- MS
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 04.09.2021
- Impfdatum
- 17.08.2021
- Beginn
- 17.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Symptomtext
got the Pfizer vaccine first dose 21 days ago and today, 17Aug2021, got a dose of the Moderna vaccine as a second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (got the Pfizer vaccine first dose 21 days ago and today, 17Aug2021, got a dose of the Moderna vaccine as a second dose) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053E21A) for COVID-19 vaccination. Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination. No Medical History information was reported. On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 17-Aug-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (got the Pfizer vaccine first dose 21 days ago and today, 17Aug2021, got a dose of the Moderna vaccine as a second dose). On 17-Aug-2021, INTERCHANGE OF VACCINE PRODUCTS (got the Pfizer vaccine first dose 21 days ago and today, 17Aug2021, got a dose of the Moderna vaccine as a second dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment medication were not reported. Patient takes some medication but nothing long term.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -